Correlation Between Pharvaris and AC Immune

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharvaris and AC Immune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and AC Immune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and AC Immune, you can compare the effects of market volatilities on Pharvaris and AC Immune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of AC Immune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and AC Immune.

Diversification Opportunities for Pharvaris and AC Immune

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pharvaris and ACIU is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and AC Immune in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AC Immune and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with AC Immune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AC Immune has no effect on the direction of Pharvaris i.e., Pharvaris and AC Immune go up and down completely randomly.

Pair Corralation between Pharvaris and AC Immune

Given the investment horizon of 90 days Pharvaris BV is expected to under-perform the AC Immune. But the stock apears to be less risky and, when comparing its historical volatility, Pharvaris BV is 1.01 times less risky than AC Immune. The stock trades about -0.05 of its potential returns per unit of risk. The AC Immune is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  300.00  in AC Immune on August 29, 2024 and sell it today you would earn a total of  40.00  from holding AC Immune or generate 13.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pharvaris BV  vs.  AC Immune

 Performance 
       Timeline  
Pharvaris BV 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Pharvaris BV are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Pharvaris unveiled solid returns over the last few months and may actually be approaching a breakup point.
AC Immune 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in AC Immune are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak forward indicators, AC Immune may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pharvaris and AC Immune Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharvaris and AC Immune

The main advantage of trading using opposite Pharvaris and AC Immune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, AC Immune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AC Immune will offset losses from the drop in AC Immune's long position.
The idea behind Pharvaris BV and AC Immune pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account